Clinical-decision context for international NPP

The treating physician’s role

In every Named Patient Program or personal-import pathway, the treating physician in the destination country is the accountable prescriber. They are the person the regulator relies on, the person the patient’s safety depends on, and the person whose signature authorizes the import. A sourcing partner can make their work faster; it cannot replace them.

What a good filing contains

A clean NPP filing typically contains: a prescription specifying drug, dose, strength, quantity, and duration; a clinical justification letter that explains the diagnosis, why registered alternatives are not appropriate, what outcome is expected, and what monitoring plan is in place; a consent form signed by the patient or legal guardian; a copy of the patient’s identity document; and supporting clinical records (imaging, pathology, prior-therapy documentation) where relevant. Country-specific filings may add an ethics-committee opinion, a pharmacovigilance commitment, or a distributor-of-record attestation.

Writing the clinical justification

The clinical justification is the single most leverage-bearing document in the filing. It should be specific rather than generic: it names the registered alternatives that have been considered and why each is inappropriate (prior failure, contraindication, unavailability, inappropriate for this patient’s phenotype); it cites the evidence base for the requested product (pivotal trial, relevant meta-analysis, or consensus guideline); and it specifies the monitoring plan, including what would trigger discontinuation. “Off-label” language should be avoided where the product is being used on-label in its source-country indication.

Documenting oversight

The treating physician’s documentation should reflect that oversight is real, not nominal. That means documented consults at clinically appropriate intervals, documented response and toxicity assessments, pharmacovigilance reporting for any adverse event, and a clear plan for continuation or discontinuation. If a sourcing partner is involved in logistics or dispensing, the physician’s notes should reflect that coordination without transferring clinical accountability.

Working with a sourcing partner

A good sourcing partner should: provide the source-country supply documentation the filing needs; be reachable by the physician (not just by the patient); respond to clinical questions with a pharmacist, not a call-center operator; and decline cases where the clinical picture does not support the request. Reserve Meds runs every case through a clinical review; if we see a reason to slow down, we say so — even if that costs us the case.

Further reading

See our physician-role explainer, our documentation guide, and our hospital ethics-committee walkthrough.

Start a request

Start a request